Fathom Cognition


Programme

Accelerate alumni

Sector

Healthcare/Pharma/Biotech


An unmet need in Alzheimer’s disease diagnostics is for scalable, culture-fair cognitive assessments that are sensitive to the very earliest disease stages. 40% of patients with cognitive impairment are not detected by GPs. 99% of Alzheimer’s clinical trials fail because recruited patients are too far progressed. Fathom Cognition (formerly NaviCog) has developed novel virtual reality cognitive assessments that meet this need. We are a team of neuroscientists and neurologists that have translated frontline cognitive neuroscience understanding to design assessments that accurately measure the first brain function altered in Alzheimer’s disease: navigation.

Our mission is to enter both international clinical trial markets as well as clinical dementia diagnostic pathways within the NHS. Our vision is to help reduce the global burden of dementia.

Top